Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Clinical trial NCT06212388 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06212388
- Sponsor
- Xijing Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-24
- Primary completion
- 2027-10-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.